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Introduction: We report one of few documented cases of a severe anaphylactic reaction with 
angioedema to polyethylene glycol (PEG). 
Case Report: The patient presented 30 minutes after onset of his symptoms and quickly 
developed hypoxia and hypotension refractory to intramuscular epinephrine, intravenous fluids, 
methylprednisolone, and supplemental oxygen via non-rebreather mask. He ultimately required 
intubation, an epinephrine infusion, and admission to the medical intensive care unit. 
Discussion: This case depicts a clinical reaction to PEG, a medication rarely implicated in severe 
anaphylaxis or angioedema. 
Conclusion: The allergenic potential of PEG-containing products should be raised, and providers 
should have a heightened awareness of these potential side effects. [Clin Pract Cases Emerg Med. 
2020;4(2):189–192.]   
Keywords: Polyethylene glycol; PEG; allergic; angioedema.
INTRODUCTION
Polyethylene glycol (PEG) is a compound found in a variety 
of products classically viewed as chemically inert substances.1 
In the medical community, it is recognized most frequently 
as the active ingredient in bowel-cleansing regimens such 
as Miralax, Go-Lytely, or Half-Lytely. It is also an additive 
in numerous other medications and substances ranging from 
intramuscular (IM) depo-provera to antibiotic tablets and 
ultrasound gel.2 Upon review of the literature, we present only 
the second published case of a severe allergic reaction involving 
both anaphylactic shock and angioedema to PEG, particularly 
unique in its severity despite typical anaphylaxis treatment. 
Fourteen cases of anaphylactic shock secondary to substances 
containing PEG have been reported; however, only one of these 
was further complicated by angioedema.3,4  In the emergency 
department (ED), this additional complication can drastically 
change management of patients, necessitating an awareness of the 
severity of this reaction to this commonly prescribed medication.
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CASE REPORT
A 76-year-old obese Caucasian male with past medical 
history of hypertension controlled with hydrochlorothiazide, 
chronic obstructive pulmonary disease on ipratropium 
bromide and albuterol, diabetes mellitus type II on metformin, 
atrial fibrillation on diltiazem and warfarin, gastroesophageal 
reflux disorder, and benign prostatic hypertrophy on 
tamsulosin presented to the ED with acute-onset shortness of 
breath. On initial examination, the patient was in respiratory 
distress, unable to speak greater than two-word phrases, with 
diffuse erythema and associated severe pruritus. He described 
an acute onset of these symptoms approximately 30 minutes 
prior to arrival to the ED. On initial evaluation, he gave us a 
piece of paper on which he had written “polyethylene glycol,” 
implicating this as the new and only medication or substance 
he had ingested in the three hours prior to presentation. 
At the time of arrival, the patient’s blood pressure (BP) 
was 177/143 millimeters of mercury (mmHg), heart rate (HR) 
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What do we already know about this clinical 
entity? 
Histaminergic angioedema and anaphylaxis are 
similar disease processes, commonly seen in 
the emergency department in various states of 
severity. 
What makes this presentation of disease 
reportable? 
Polyethylene glycol (PEG) is thought to be 
minimally immunogenic; however, this case 
report shows it may have severe allergic 
potential in some patients.
What is the major learning point? 
All medications should be considered in an 
anaphylactic reaction. 
How might this improve emergency medicine 
practice? 
Emergency physicians may more readily anticipate 
severe reactions and a difficult airway if patients 
present with signs and symptoms of allergy to 
products containing PEG.
163 beats per minute (bpm), respiratory rate (RR) 23 breaths 
per minute, oxygen saturation of 93% on room air, weight 103 
kilograms (kg). He was in acute respiratory distress in tripod 
position, with an urticarial eruption on his trunk. Auscultation 
was significant for inspiratory and expiratory wheezes in all lung 
fields. Oropharyngeal exam revealed an edematous soft palate 
with a brawny texture and elevation of his tongue to the hard 
palate, with associated difficulty tolerating his oral secretions. 
The patient immediately received 0.3 milligrams (mg) of 
IM epinephrine, 125 mg intravenous (IV) methylprednisolone, 
50 mg IV diphenhydramine, 20 mg IV famotidine, and 
one liter 0.9% normal saline. Despite these interventions, 
the patient deteriorated rapidly, demonstrating signs of 
anaphylactic shock. His BP decreased to 63/42 mmHg, with 
a HR of 173 bpm, RR of 34 breaths per minute, and oxygen 
saturation of 78% on room air. It was determined that the 
patient would need intubation and further resuscitation with 
IV fluids and an epinephrine infusion to maintain his blood 
pressure in the setting of respiratory failure and anaphylactic 
shock. His oxygenation improved to 93% with application of 
supplemental oxygen via a non-rebreather mask at 15 liters 
per minute, and he maintained his mentation; thus, we elected 
to use fiberoptic nasopharyngoscopy to evaluate the airway for 
concern of significant oropharyngeal edema and the potential 
for a complicated endotracheal intubation.
The patient’s oropharynx was prepped with topical 
benzocaine spray, and a 6.0 endotracheal tube (ETT) was 
loaded on the fiberoptic scope in preparation for emergent 
nasotracheal intubation if necessary during the procedure. 
On visualization of the pharynx, he was noted to have edema 
extending to the area of the hypopharynx, sparing the epiglottis 
and vocal cords. We elected to proceed with rapid sequence 
endotracheal intubation after evaluation of his airway. The 
intubation was performed with 200 mg IV ketamine and 200 
mg IV succinylcholine. Video laryngoscopy using a 7.0 ETT 
resulted in first-pass success. An in-line albuterol nebulizer was 
then initiated. To allow for central hemodynamic monitoring 
and accurate titration of the patient’s epinephrine infusion, 
right femoral central and arterial lines were placed with goal 
to maintain a mean arterial pressure of greater than 65 mmHg. 
The patient was subsequently admitted to the medical intensive 
care unit in critical condition.
DISCUSSION
PEGs are polymers composed of ethylene oxide that are 
non-ionic and hydrophilic and are thought to be chemically 
inert.1 They are commonly used in industry production of 
medications, medical products, and cosmetics.1 Given its 
chemical structure as a large hydrophilic polymer, it is effective 
as a bowel regimen as it does not readily cross the mucosal 
surface of the gastrointestinal tract.4,6 Due to this inherent 
quality, the compound has generally been viewed as minimally 
antigenic or reactive.6 However, larger PEG polymers (>1000 
atomic mass units) have immunogenic properties as they are 
likely large enough to elicit immune responses.6 While in 
general these are poorly absorbed, it has been demonstrated 
that PEG polymers can be recovered in the urine and would, 
therefore, be able to elicit immune responses in these subjects.7 
Of those cases with reported reactions to PEG-containing 
products, the majority of patients present with simple urticaria 
or meet criteria of anaphylaxis with greater than two body 
systems involved.3,8 However, more severe reactions involving 
anaphylactic shock and occurrences of ventricular arrhythmias 
have been documented.3,9 Wenande et al recently reported a 
summary of the known cases of allergic reactions to PEG-
containing products.3 Of those reported, fewer than 20 patients 
experienced cardiovascular collapse indicative of anaphylactic 
shock and only one with co-existing angioedema.3 All cases 
reported with discussion of patient management detailed 
resolution of anaphylactic symptoms and angioedema over 
the course of hours with recurrent dosing of epinephrine, 
antihistamines, and steroids.3
Our case differed in severity to those cited above, as the 
patient’s quick decompensation necessitated an escalation 
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in treatment. The primary change in management was 
introduction of continuous IV epinephrine to support BP. 
Current guidelines support administration of IM epinephrine 
to stable patients demonstrating anaphylaxis; however, they 
recommend administration of IV epinephrine if anaphylaxis 
appears to be severe with an immediate life-threatening 
manifestation. The recommended starting infusion rate 
is between 1-4 micrograms per minute.10 Other treatment 
modalities remained the same, including steroid dosing and 
use of H1 (histamine type 1) and H2 antagonists. 
The case reported here also presented a potentially difficult 
endotracheal intubation secondary to the significant angioedema 
visualized on his initial bedside oropharyngeal exam. It was 
presumed to be resultant of a histaminergic reaction given the 
concurrent anaphylaxis, as opposed to a non-histaminergic 
cause, such as bradykinin-mediated or hereditary angioedema, 
which would require a different treatment regimen.11 The 
patient was not actively taking angiotensin-converting-
enzyme inhibitors for hypertension, one of the most implicated 
substances in bradykinin-mediated angioedema.12 He had not 
previously had an allergic reaction or edema of his lips or 
oropharynx to any other substance per his report. He also had 
no personal or family history of similar presentations, which 
makes it unlikely that he suffers from hereditary angioedema.12
 Histaminergic angioedema is a subtype of angioedema 
caused by a deep tissue reaction initiated by histamine 
release from mast cells, and by subsequent immunoglobulin 
E-mediated complement activation.2 It causes vasodilation 
and vascular permeability, typically affecting the perioral 
and periorbital regions, but can also be seen as a non-pitting 
edema of the extremities and abdomen.5 When this reaction 
localizes to the oropharyngeal structures, endotracheal 
intubation may become extremely challenging due to severe 
hypopharyngeal and vocal cord edema. 
Studies vary on prevalence of airway obstruction with 
angioedema; however, in general about 15% of all types of 
angioedema cases require intubation, and 50% of those needing 
a definitive airway require cricothyrotomy or tracheostomy.12 
We identified no recent studies with a PubMed search on rates 
of intubation in histamine-mediated angioedema specifically. 
Histaminergic angioedema is mediated by the cytokine and 
histamine activation implicated in anaphylaxis, and the use 
of antihistamines, steroids, and epinephrine is regarded as the 
standard of care.12 Treatment regimens for bradykinin-induced 
and hereditary angioedema continue to be controversial.2,11 
Regardless of the cause, ensuring establishment of a definitive 
airway, when needed, is paramount.
CONCLUSION
The exact mechanism of PEG-induced anaphylaxis has 
not yet been fully elucidated. It is likely initiated by uptake 
of PEG molecules across the gastrointestinal mucosa, and 
its large molecular weight and hydrophilicity prolongs this 
process. We suspect that the patient was therefore able to 
tolerate a significant ingestion prior to onset of symptoms, 
and the amount ingested was likely the cause of his rapid 
deterioration to anaphylactic shock, despite the appropriate 
initial management for anaphylaxis. Although the associated 
side effects of PEGs are commonly restricted to abdominal 
discomfort, bloating, cramping, and nausea, case reports 
like this one suggest a need for increased awareness in 
all specialties that regularly prescribe these medications. 
Emergency providers should be especially aware of this 
reported complication of PEG-containing products as rapid 
identification and resuscitation is key to improving morbidity 
and mortality in these patients.
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